High-performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine of cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-02-17
著者
-
ZUCCHETTI Massimo
Laboratory of Cancer Pharmacology, Department of Oncology, Mario Negri Institute for Pharmacological
-
De Fusco
Laboratory Of Cancer Chemotherapy Mario Negri Institute For Pharmacological Research
-
Reichert Sonja
Asta Medica
-
GENTILI Donatella
Laboratory of Cancer Chemotherapy, Mario Negri Institute for Pharmacological Research
-
Zucchetti Massimo
Laboratory Of Cancer Chemotherapy Mario Negri Institute For Pharmacological Research
-
Gentili Donatella
Laboratory Of Cancer Chemotherapy Mario Negri Institute For Pharmacological Research
関連論文
- Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry
- Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
- Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
- High-performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine of cancer patients